Antioxidant Nanozyme‐Engineered Mesenchymal Stem Cells for In Vivo MRI Tracking and Synergistic Therapy of Myocardial Infarction
Advanced Functional Materials · 2024-06 · 34 (23)
DOI: 10.1002/adfm.202314328 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 14.02.2024. Verfasst von Wenjun Le und 11 weiteren Autor:innen. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Health Commission.
Abstract (Originalsprache)
Cell therapy is a promising approach for myocardial infarction (MI) treatment. However, this strategy is often restricted by the harsh microenvironment of MI, such as excess ROS, high oxidative stress, inflammation, etc., and thus decreases the curative effect. Additionally, the distribution, migration, and homing of the transplanted stem cells is ambiguous, which also becomes a bottleneck for clinical translation. To address these challenges, herein, a versatile antioxidant nanozyme is designed by polymerically modifying dopamine (PDA) onto the surface of Mn 3 O 4 . The obtained nanozyme acts as an efficient SOD mimic, eliminating ROS, relieving oxidative stress, and reducing inflammation to improve the MI microenvironment. Simultaneously, Mn 3 O 4 @PDA serves as an excellent MRI contrast agent for tracking MSCs. Then, MSCs are engineered with Mn 3 O 4 @PDA nanozyme via endocytosis to form Mn 3 O 4 @PDA‐MSCs (Abbr. E‐MSCs), which possess superior viability, migration and homing ability compared to normal MSCs. Furthermore, E‐MSCs exhibit superior anti‐oxidant and anti‐inflammatory activity, thereby enhancing the therapeutic efficacy of MSCs. Finally, the in vivo MRI tracking and synergistic therapy potential of E‐MSCs is explored in MI model mice. Overall, this work provides a strategy to combine antioxidant activity and imaging properties of nanozymes to simultaneously facilitate imaging tracking of stem cells and improve MI treatment.
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Health Commission
Zitieren
APA
Le, W., Sun, Z., Li, T., Cao, H., Yang, C., Mei, T., Zhang, L., Wang, Y., Jia, W., Sun, W., Hu, Y., & Liu, Z. (2024). Antioxidant Nanozyme‐Engineered Mesenchymal Stem Cells for In Vivo MRI Tracking and Synergistic Therapy of Myocardial Infarction. Advanced Functional Materials, 34(23). https://doi.org/10.1002/adfm.202314328
Vancouver
Le W, Sun Z, Li T, Cao H, Yang C, Mei T, et al. Antioxidant Nanozyme‐Engineered Mesenchymal Stem Cells for In Vivo MRI Tracking and Synergistic Therapy of Myocardial Infarction. Advanced Functional Materials. 2024;34(23). doi:10.1002/adfm.202314328
BibTeX
@article{Le2024,
author = {Le, Wenjun and Sun, Zeyi and Li, Tieyan and Cao, Hao and Yang, Chuanxue and Mei, Tianxiao and Zhang, Laihai and Wang, Yibing and Jia, Wenwen and Sun, Wen and Hu, Yihui and Liu, Zhongmin},
title = {Antioxidant Nanozyme‐Engineered Mesenchymal Stem Cells for In Vivo MRI Tracking and Synergistic Therapy of Myocardial Infarction},
journal = {Advanced Functional Materials},
year = {2024},
volume = {34},
number = {23},
doi = {10.1002/adfm.202314328}
}
EUVIMED